159 related articles for article (PubMed ID: 37450087)
1. S100A8 gene copy number and protein expression in breast cancer: associations with proliferation, histopathological grade and molecular subtypes.
Børkja MLB; Giambelluca MS; Ytterhus B; Prestvik WS; Bjørkøy G; Bofin AM
Breast Cancer Res Treat; 2023 Sep; 201(2):339-350. PubMed ID: 37450087
[TBL] [Abstract][Full Text] [Related]
2. Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.
Miller P; Kidwell KM; Thomas D; Sabel M; Rae JM; Hayes DF; Hudson BI; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2017 Nov; 166(1):85-94. PubMed ID: 28717852
[TBL] [Abstract][Full Text] [Related]
3. ZNF703 gene copy number and protein expression in breast cancer; associations with proliferation, prognosis and luminal subtypes.
Klæstad E; Sawicka JE; Engstrøm MJ; Ytterhus B; Valla M; Bofin AM
Breast Cancer Res Treat; 2021 Feb; 186(1):65-77. PubMed ID: 33389351
[TBL] [Abstract][Full Text] [Related]
4. CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.
Valla M; Klæstad E; Ytterhus B; Bofin AM
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):67-77. PubMed ID: 35459982
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.
Woo JW; Chung YR; Kim M; Choi HY; Ahn S; Park SY
Cancer Immunol Immunother; 2021 May; 70(5):1365-1378. PubMed ID: 33146829
[TBL] [Abstract][Full Text] [Related]
6. The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients.
Li YH; Liu HT; Xu J; Xing AY; Zhang J; Wang YW; Yin G; Gao P
Hum Pathol; 2018 Apr; 74():156-163. PubMed ID: 29320752
[TBL] [Abstract][Full Text] [Related]
7. MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes.
Klæstad E; Opdahl S; Engstrøm MJ; Ytterhus B; Wik E; Bofin AM; Valla M
Breast Cancer Res Treat; 2020 Feb; 180(1):73-86. PubMed ID: 31950385
[TBL] [Abstract][Full Text] [Related]
8. The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis.
Vrakas CN; O'Sullivan RM; Evans SE; Ingram DA; Jones CB; Phuong T; Kurt RA
Immunol Invest; 2015; 44(2):174-88. PubMed ID: 25255046
[TBL] [Abstract][Full Text] [Related]
9. PAK1 copy number in breast cancer-Associations with proliferation and molecular subtypes.
Skjervold AH; Valla M; Ytterhus B; Bofin AM
PLoS One; 2023; 18(6):e0287608. PubMed ID: 37368917
[TBL] [Abstract][Full Text] [Related]
10. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
11. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
[TBL] [Abstract][Full Text] [Related]
12.
Bofin AM; Ytterhus B; Klæstad E; Valla M
J Clin Pathol; 2022 Jul; 75(7):459-464. PubMed ID: 33753561
[TBL] [Abstract][Full Text] [Related]
13. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy.
Minner S; Hager D; Steurer S; Höflmayer D; Tsourlakis MC; Möller-Koop C; Clauditz TS; Hube-Magg C; Luebke AM; Simon R; Sauter G; Göbel C; Weidemann S; Lebok P; Dum D; Fraune C; Izbicki J; Burandt E; Schlomm T; Huland H; Heinzer H; Haese A; Graefen M; Heumann A
Neoplasia; 2019 Sep; 21(9):872-881. PubMed ID: 31382165
[TBL] [Abstract][Full Text] [Related]
15. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.
Arai K; Takano S; Teratani T; Ito Y; Yamada T; Nozawa R
Curr Cancer Drug Targets; 2008 Jun; 8(4):243-52. PubMed ID: 18537548
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
Parris TZ; Kovács A; Aziz L; Hajizadeh S; Nemes S; Semaan M; Forssell-Aronsson E; Karlsson P; Helou K
Int J Cancer; 2014 Apr; 134(7):1617-29. PubMed ID: 24114735
[TBL] [Abstract][Full Text] [Related]
17. DTX3 copy number increase in breast cancer: a study of associations to molecular subtype, proliferation and prognosis.
Valla M; Opdahl S; Ytterhus B; Bofin AM
Breast Cancer Res Treat; 2021 May; 187(1):57-67. PubMed ID: 33616774
[TBL] [Abstract][Full Text] [Related]
18. Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells.
Tanriover G; Eyinc MB; Aliyev E; Dilmac S; Erin N
Clin Breast Cancer; 2018 Oct; 18(5):e1067-e1076. PubMed ID: 29804651
[TBL] [Abstract][Full Text] [Related]
19. The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatment.
Taub CJ; Lippman ME; Hudson BI; Blomberg BB; Diaz A; Fisher HM; Nahin ER; Lechner SC; Kwak T; Hwang GH; Antoni MH
Cancer; 2019 May; 125(10):1717-1725. PubMed ID: 30633331
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancer.
Li J; Su W; Zhang S; Hu Y; Liu J; Zhang X; Bai J; Yuan W; Hu L; Cheng T; Zetterberg A; Lei Z; Zhang J
Cancer Sci; 2015 May; 106(5):642-9. PubMed ID: 25702787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]